PLoS ONE (Jun 2009)

Heme oxygenase-1 accelerates cutaneous wound healing in mice.

  • Anna Grochot-Przeczek,
  • Radoslaw Lach,
  • Jacek Mis,
  • Klaudia Skrzypek,
  • Malgorzata Gozdecka,
  • Patrycja Sroczynska,
  • Milena Dubiel,
  • Andrzej Rutkowski,
  • Magdalena Kozakowska,
  • Anna Zagorska,
  • Jacek Walczynski,
  • Halina Was,
  • Jerzy Kotlinowski,
  • Justyna Drukala,
  • Krzysztof Kurowski,
  • Claudine Kieda,
  • Yann Herault,
  • Jozef Dulak,
  • Alicja Jozkowicz

DOI
https://doi.org/10.1371/journal.pone.0005803
Journal volume & issue
Vol. 4, no. 6
p. e5803

Abstract

Read online

Heme oxygenase-1 (HO-1), a cytoprotective, pro-angiogenic and anti-inflammatory enzyme, is strongly induced in injured tissues. Our aim was to clarify its role in cutaneous wound healing. In wild type mice, maximal expression of HO-1 in the skin was observed on the 2(nd) and 3(rd) days after wounding. Inhibition of HO-1 by tin protoporphyrin-IX resulted in retardation of wound closure. Healing was also delayed in HO-1 deficient mice, where lack of HO-1 could lead to complete suppression of reepithelialization and to formation of extensive skin lesions, accompanied by impaired neovascularization. Experiments performed in transgenic mice bearing HO-1 under control of keratin 14 promoter showed that increased level of HO-1 in keratinocytes is enough to improve the neovascularization and hasten the closure of wounds. Importantly, induction of HO-1 in wounded skin was relatively weak and delayed in diabetic (db/db) mice, in which also angiogenesis and wound closure were impaired. In such animals local delivery of HO-1 transgene using adenoviral vectors accelerated the wound healing and increased the vascularization. In summary, induction of HO-1 is necessary for efficient wound closure and neovascularization. Impaired wound healing in diabetic mice may be associated with delayed HO-1 upregulation and can be improved by HO-1 gene transfer.